Methods for reformulating and repositioning pharmaceutical data and devices thereof

A pharmaceutical assessment computing device, comprising:

• at least one processor;
• and
• a memory, wherein the memory is coupled to the at least one processor which is configured to be capable of executing programmed instructions, which comprise the programmed instructions stored in the memory to:
• obtain (1) therapeutic area data comprising at least one medical condition, pathogenesis parameters and associated pathogenesis values, and (2) pharmaceutical molecule data corresponding to the at least one medical condition, wherein the pharmaceutical molecule data comprises a set of pharmaceutical molecule identifiers, and mechanism of action parameters and associated mechanism of action values for each pharmaceutical molecule identifier of the set of pharmaceutical molecule identifiers;
• refine a number of pharmaceutical molecule identifiers for analysis by the at least one processor to define a subset of pharmaceutical molecule identifiers from the set of pharmaceutical molecule identifiers by mapping the mechanism of action parameters to the pathogenesis parameters using the associated pathogenesis values and the associated mechanism of action values and selecting tags associated with the mechanism of action parameters and tags associated with the pathogenesis parameters to define usage data parameters including mapped mechanism of action parameters and usage data values including mapped mechanism of action values;
• compare each of the usage data values to a corresponding usage threshold value;
• determine, one or more different delivery mechanisms for each pharmaceutical molecule identifier from the subset of pharmaceutical molecule identifiers comprising a usage data value that exceeds the corresponding usage threshold value, the one or more different delivery mechanisms being associated with the usage data parameters and associated usage data values corresponding to the pharmaceutical molecule identifiers from the subset of pharmaceutical molecule identifiers comprising a usage data value that exceeds the corresponding usage threshold value;
• and
• provide a pharmaceutical molecule report based on the one or more different delivery mechanisms.

A non-transitory computer readable medium having stored thereon instructions for assessing pharmaceutical data, comprising machine executable code which when executed by at least one processor, causes the at least one processor to perform steps comprising:

• obtaining (1) therapeutic area data comprising at least one medical condition, pathogenesis parameters and associated pathogenesis values, and (2) pharmaceutical molecule data corresponding to the at least one medical condition, wherein the pharmaceutical molecule data comprises a set of pharmaceutical molecule identifiers, and mechanism of action parameters and associated mechanism of action values for each pharmaceutical molecule identifier of the set of pharmaceutical molecule identifiers;
• refining a number of pharmaceutical molecule identifiers for analysis by the at least one processor to define a subset of pharmaceutical molecule identifiers from the set of pharmaceutical molecule identifiers by mapping the mechanism of action parameters to the pathogenesis parameters using the associated pathogenesis values and the associated mechanism of action values and selecting tags associated with the mechanism of action parameters and tags associated with the pathogenesis parameters to define usage data parameters including mapped mechanism of action parameters and usage data values including mapped mechanism of action values;
• comparing each of the usage data values to a corresponding usage threshold value;
• determining, one or more different delivery mechanisms for each pharmaceutical molecule identifier from the subset of pharmaceutical molecule identifiers comprising a usage data value that exceeds the corresponding usage threshold value, the one or more different delivery mechanisms being associated with the usage data parameters and associated usage data values corresponding to the pharmaceutical molecule identifiers from the subset of pharmaceutical molecule identifiers comprising a usage data value that exceeds the corresponding usage threshold value;
• and
• providing a pharmaceutical molecule report based on the one or more different delivery mechanisms.